← Insider buys
RUBY

Rubius Therapeutics, Inc.

Director David R Epstein sold $399K of Rubius Therapeutics, Inc.

Sold$398,560
$14.93Price
26,704Shares
−1%Stake

What RUBY did after the filing

Prices for RUBY after this filing aren't in yet.

Traded Thu, Feb 11. Filed Tue, Feb 16, 9:51 PM ET, after the close. Not investment advice.